scispace - formally typeset
G

Gabriella Gruden

Researcher at University of Turin

Publications -  166
Citations -  10657

Gabriella Gruden is an academic researcher from University of Turin. The author has contributed to research in topics: Diabetes mellitus & Type 2 diabetes. The author has an hindex of 39, co-authored 158 publications receiving 7243 citations. Previous affiliations of Gabriella Gruden include King's College London & Guy's Hospital.

Papers
More filters
Journal ArticleDOI

Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults

Leandra Abarca-Gómez, +1024 more
- 16 Dec 2017 - 
TL;DR: Trends in mean BMI have recently flattened in northwestern Europe and the high-income English-speaking and Asia-Pacific regions for both sexes, southwestern Europe for boys, and central and Andean Latin America for girls, and by contrast, the rise in BMI has accelerated in east and south Asia forboth sexes, and southeast Asia for boys.
Journal ArticleDOI

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants

Bin Zhou, +1144 more
- 11 Sep 2021 - 
TL;DR: In this article, a Bayesian hierarchical model was used to estimate the prevalence of hypertension and the proportion of people with hypertension who had a previous diagnosis (detection), who were taking medication for hypertension (treatment), and whose hypertension was controlled to below 140/90 mm Hg (control).
Journal ArticleDOI

Urinary exosomal microRNAs in incipient diabetic nephropathy.

TL;DR: In this article, the miRNA expression in urinary exosomes from type 1 diabetic patients with and without incipient diabetic nephropathy was assessed and miR-145 levels were increased and this was paralleled by miR145 overexpression within the glomeruli.
Journal ArticleDOI

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial

Olga Vaccaro, +378 more
TL;DR: In this long-term, pragmatic trial, incidence of cardiovascular events was similar with sulfonylureas and pioglitazone as add-on treatments to metformin, although piog litazone was associated with fewer hypoglycaemia events.